Holen Sie sich die Stockscreener-App
1.405
7.11%
-0.105
Schlusskurs vom Vortag:
$1.51
Offen:
$1.485
24-Stunden-Volumen:
3.22M
Relative Volume:
1.49
Marktkapitalisierung:
$19.57M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-8.83M
KGV:
-1.7771
EPS:
-0.7906
Netto-Cashflow:
$-8.61M
1W Leistung:
+40.26%
1M Leistung:
+38.87%
6M Leistung:
+14.97%
1J Leistung:
-1.23%
1-Tages-Spanne:
$1.34
$1.52
1-Wochen-Bereich:
$1.00
$2.0299
52-Wochen-Spanne:
$0.8588
$2.67
Cocrystal Pharma Inc Stock (COCP) Company Profile
Firmenname
Cocrystal Pharma Inc
Sektor
Branche
Telefon
(786) 459-1831
Adresse
19805 N. CREEK PARKWAY, BOTHELL, WA
Compare COCP vs VRTX, REGN, ARGX, ALNY, INSM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
COCP
Cocrystal Pharma Inc
|
1.42 | 20.81M | 0 | -8.83M | -8.61M | -0.7906 |
VRTX
Vertex Pharmaceuticals Inc
|
436.02 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
758.56 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
747.90 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
330.10 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
164.78 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Cocrystal Pharma Inc Stock (COCP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2020-07-08 | Eingeleitet | H.C. Wainwright | Buy |
Cocrystal Pharma Inc Aktie (COCP) Neueste Nachrichten
Why Cocrystal Pharma Shares Are Cooling Off Monday? - Benzinga
Cocrystal Pharma, Inc. (COCP) stock price, news, quote and history - Yahoo Finance UK
COCP PE Ratio & Valuation, Is COCP Overvalued - Intellectia AI
We're Keeping An Eye On Cocrystal Pharma's (NASDAQ:COCP) Cash Burn Rate - Yahoo Finance
Shares +48% after hours: COCP Cocrystal Pharma NASDAQ 03 Apr earnings spotlight - meyka.com
12 Health Care Stocks Moving In Thursday's Intraday Session - Sahm
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Sahm
Crude Oil Rises Sharply; Acuity Shares Fall After Q2 Results - Sahm
Cocrystal Pharma Shares Soar After FDA Grants Fast Track Status To CDI-988 - Sahm
Cocrystal Pharma (COCP) Receives FDA Fast Track Status for Norov - GuruFocus
Cocrystal Pharma stock surges on FDA Fast Track designation - Investing.com
Cocrystal Pharma stock surges on FDA Fast Track designation By Investing.com - Investing.com Canada
Cocrystal Pharma, Inc. (8CC.F) stock price, news, quote and history - Yahoo Finance UK
Nasdaq Down 1%; US Initial Jobless Claims Fall - Benzinga
Cocrystal Pharma Advances in Norovirus Study as Financial Challenges Loom - StocksToTrade
Cocrystal Pharma Wins FDA Fast Track for Norovirus Drug - TipRanks
COCP Stock Soars 75% — What Is The Link To Cocrystal’s Norovirus Treatment? - Stocktwits
Cocrystal Pharma Advances Antiviral Trials Amid Financial Strategy Shift - timothysykes.com
FDA Fast Track backs Cocrystal (Nasdaq: COCP) oral norovirus antiviral CDI-988 - Stock Titan
Cocrystal Pharma, Inc. announced that its antiviral candidate drug Cdi-988 has been granted Fast Track designation by the U.S. Food and Drug Administration (FDA). - Bitget
Cocrystal Pharma Receives FDA Fast Track Designation for CDI-988 for Norovirus Infection Treatment and Preventive - Yahoo Finance
COCP Stock Price, Quote & Chart | COCRYSTAL PHARMA INC (NASDAQ:COCP) - ChartMill
COCP gets FDA Fast Track for CDI-988 norovirus drug, stock up 75% | Tap to know more | Inshorts - Inshorts
Cocrystal begins norovirus challenge study, reports 2025 results By Investing.com - Investing.com South Africa
Cocrystal Pharma Reports 2025 Financial Results and Advances Norovirus and Influenza Antiviral Drug Pipeline - Minichart
Cocrystal Pharma 2025 Research and Development Expenses $5.1M >COCP - Moomoo
Cocrystal Pharma Reports 2025 Financial Results, Advances Antiviral Drug Programs - National Today
Cocrystal Pharma Reports 2025 Financial Results - National Today
[10-K] Cocrystal Pharma, Inc. Files Annual Report - Stock Titan
Cocrystal begins norovirus challenge study, reports 2025 results - Investing.com
Cocrystal Pharma 2025 10-K: $0 Revenue, $(0.78) EPS, $(8.83)M Net Loss - TradingView
Cocrystal Pharma reports 2025 net loss $8.8M, cash $7.7M, advances norovirus CDI-988 into Phase 1b - TradingView
Cocrystal Pharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Cocrystal Pharma (NASDAQ: COCP) cuts 2025 loss to $8.8M and advances antivirals - Stock Titan
Cocrystal Pharma, Inc. recently released its financial report for fiscal year 2025 and provided an update on the latest progress in its antiviral drug development projects. - Bitget
Cocrystal Pharma 2025 net loss narrows as R&D expenses fall - TradingView
BRIEF-Cocrystal Pharma FY Net Income USD -8.831 Million - TradingView
Cocrystal Pharma Reports 2025 Financial Results and Provides Updates on its Antiviral Drug-Development Programs - GlobeNewswire
Institution Moves: Can Cocrystal Pharma Inc ride the EV waveEarnings Recap Report & Real-Time Volume Surge Alerts - baoquankhu1.vn
Insider Buy: Is Cocrystal Pharma Inc stock technically oversold2026 Spike Watch & Verified Swing Trading Watchlists - baoquankhu1.vn
Cocrystal Pharma Inc expected to post a loss of 17 cents a shareEarnings Preview - TradingView
If You Invested $1,000 in Cocrystal Pharma Inc (COCP) - Stock Titan
COCP SEC FilingsCocrystal Pharma Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Aug Levels: Can Cocrystal Pharma Inc keep up with sector leaders2026 Update & High Conviction Buy Zone Alerts - baoquankhu1.vn
Cocrystal Pharma Announces Passing of Board Member Japour - The Globe and Mail
Cocrystal begins dosing patients in norovirus challenge study - Investing.com Nigeria
Cocrystal Pharma, Inc. Announces Passing of Board Member Dr. Anthony Japour in March 2026 9 - Minichart
Cocrystal Pharma (COCP) reports death of board director Japour - Stock Titan
Why is Cocrystal Pharma Inc stock going up2026 Bull vs Bear & Real-Time Price Movement Reports - baoquankhu1.vn
COCP|Cocrystal Pharma Inc|Price:1.030|Chg%:-0.03 - TradingKey
Cocrystal begins dosing patients in norovirus challenge study By Investing.com - Investing.com South Africa
Finanzdaten der Cocrystal Pharma Inc-Aktie (COCP)
Umsatz
Nettogewinn
Free Cashflow
ENV
Cocrystal Pharma Inc-Aktie (COCP) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| FROST PHILLIP MD ET AL | Director |
Feb 06 '26 |
Buy |
0.95 |
50,000 |
47,280 |
1,888,551 |
| FROST PHILLIP MD ET AL | Director |
Dec 31 '25 |
Buy |
0.95 |
50,000 |
47,275 |
1,838,551 |
| FROST PHILLIP MD ET AL | Director |
Dec 30 '25 |
Buy |
0.97 |
20,000 |
19,310 |
1,788,551 |
| FROST PHILLIP MD ET AL | Director |
Dec 26 '25 |
Buy |
0.97 |
40,000 |
38,944 |
1,768,551 |
| FROST PHILLIP MD ET AL | Director |
Dec 24 '25 |
Buy |
0.97 |
25,000 |
24,258 |
1,728,551 |
| FROST PHILLIP MD ET AL | Director |
Nov 26 '25 |
Buy |
0.99 |
4,000 |
3,975 |
1,703,551 |
| FROST PHILLIP MD ET AL | Director |
Nov 25 '25 |
Buy |
0.94 |
20,000 |
18,812 |
1,699,551 |
1.90%
1.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):